"Novel Inhibitors of T315I Mutant BCR-ABL1 Tyrosine Kinase for Chronic ..."

Satya Anindita et al. (2018)

> Home

Details and statistics

DOI: 10.1007/978-3-319-94968-0_17

access: closed

type: Conference or Workshop Paper

metadata version: 2018-11-02

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - conf/isbra/AninditaMPHT18
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/isbra/AninditaMPHT18
Satya Anindita, Atika Marnolia, Hersal Hermana Putra, Muhammad Chandra Haikal, Usman Sumo Friend Tambunan:
Novel Inhibitors of T315I Mutant BCR-ABL1 Tyrosine Kinase for Chronic Myeloid Leukemia Disease Through Fragment-Based Drug Design. ISBRA 2018: 185-190

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.